Efficacy of Dupilumab in Children With Uncontrolled, Moderate-to-Severe Type 2 Asthma, With/Without Evidence of Allergic Asthma: The VOYAGE Phase 3 Study
Sunday, April 24, 2022
10:00 AM – 10:15 AM US MT
Location: Convention Center: 507
CE: Enduring CME: 0.25
Publication Number: 2225.1
Nikolaos G. Papadopoulos, Allergy Dpt, 2nd Pediatric Clinic, University of Athens, Athens, Attiki, Greece; Stanley J. Szefler, University of Colorado School of Medicine, Aurora, CO, United States; Leonard B. Bacharier, Monroe Carell Jr Children’s Hospital at Vanderbilt University Medical Center, Nashville, TN, United States; jorge f. maspero, Fundacion Cidea, Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina; Christian Domingo, Autonomous University of Barcelona, Barcelona, Catalonia, Spain; Nadia Daizadeh, Sanofi, Cambridge, MA, United States; David J. Lederer, Regeneron Pharmaceuticals, Tarrytown, NY, United States; Megan Hardin, Sanofi Genzyme, Cambridge, MA, United States; Juby A. Jacob-Nara, Sanofi, Bridgewater, NJ, United States; Yamo Deniz, Regeneron, Tarrytown, NY, United States; Rebecca Gall, Regeneron Pharmaceuticals, Sleepy Hollow, NY, United States; Benjamin Ortiz, Regeneron Pharmaceuticals Inc, Haworth, NJ, United States; Michel Djandji, Sanofi pharmaceuticals, Boston, MA, United States; Paul J. Rowe, Sanofi, Bridgewater, NJ, United States
Presenting Author(s)
Stanley J. Szefler, MD
Professor of Pediatrics University of Colorado School of Medicine Aurora, Colorado, United States
Participants should be aware of the following financial/non-financial relationships:
Stanley J. Szefler, MD: ● Astra Zeneca (Currently Ongoing) (Products/Services: Consultant). ● GlaxoSmithKline (Ended In the Past 24 Months) (Products/Services: Advisory Committee). ● Moderna (Currently Ongoing) (Products/Services: Consultant). ● Propeller Health (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Regeneron (Currently Ongoing) (Products/Services: Consultant). ● Sanofi (Ended In the Past 24 Months) (Products/Services: Advisory Committee).
Nikolaos G. Papadopoulos, MD: ● AstraZeneca (Currently Ongoing) (Products/Services: Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Boehringer Ingelheim (Ended In the Past 24 Months) (Products/Services: Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● GSK (Ended In the Past 24 Months) (Products/Services: Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● HAL Allergy (Ended In the Past 24 Months) (Products/Services: Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Menarini (Currently Ongoing) (Products/Services: Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Mylan (Currently Ongoing) (Products/Services: Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Novartis (Currently Ongoing) (Products/Services: Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Nutricia (Currently Ongoing) (Products/Services: Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● OM Pharma (Currently Ongoing) (Products/Services: Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Regeneron Pharmaceuticals, Inc. (Currently Ongoing) (Products/Services: Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Sanofi (Currently Ongoing) (Products/Services: Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness).
Leonard B. Bacharier: ● AstraZeneca (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Cystic Fibrosis Foundation (Currently Ongoing) (Products/Services: Advisory Committee). ● DBV Technologies (Currently Ongoing) (Products/Services: Advisory Committee). ● GSK (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● NIH (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Regeneron Pharmaceuticalst, Inc. (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Sanofi (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Vectura (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).
jorge f. maspero, MD: ● ASTRAZENECA (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Contractor including contracted research, Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● GSK (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● INMUNOTEK (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● MSD (Currently Ongoing) (Products/Services: Contractor including contracted research, Advisory Committee). ● NOVARTIS (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Contractor including contracted research, Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● SANOFI (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant, Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● URIACH (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness).
Christian Domingo, MD: ● ALK (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Allergy Therapeutics (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● AstraZeneca (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Boehringer Ingelheim (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Chiesi (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● GSK (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● HAL Allergy (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Immunotek (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Menarini (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Novartis (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Pfizer (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● sanofi-aventis (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Stallergenes Greer (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Teva (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness).
Nadia Daizadeh, PhD: ● Sanofi (Currently Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
David J. Lederer, MD, MS: ● Regeneron Pharmaceuticals (Currently Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
Megan Hardin, MD MPH: ● Sanofi Genzyme (Currently Ongoing) (Products/Services: Employment with an ineligible company).
Juby A. Jacob-Nara, MD, MPH, MBA, DHSc: ● Sanofi (Currently Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
Yamo Deniz, MD: ● Regeneron (Currently Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
Rebecca Gall, MD: ● Regeneron Pharmaceuticals (Currently Ongoing) (Products/Services: Employment with an ineligible company).
Benjamin Ortiz, MD: ● Regeneron Pharmaceuticals Inc (Currently Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
Michel Djandji, M.D.: ● Sanofi pharmaceuticals (Currently Ongoing) (Products/Services: Employment with an ineligible company).
Paul J. Rowe, MD: ● Sanofi (Currently Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).